298 related articles for article (PubMed ID: 10137847)
1. How to develop a proactive formulary system.
Crane VS; Gonzalez ER; Hull BL
Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
[TBL] [Abstract][Full Text] [Related]
2. How to use structured decision making in developing therapeutic, cost-effective formulary systems.
Crane VS
Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomics and the formulary decision-making process.
Bakst A
Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
[TBL] [Abstract][Full Text] [Related]
4. Survey of formulary system policies and procedures.
Rascati KL
Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
[TBL] [Abstract][Full Text] [Related]
5. P & T Committee formulary requests: criteria for admission.
Weintraub M; Guttmacher L
Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
Skaer TL
Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
[TBL] [Abstract][Full Text] [Related]
7. P & T Committee interview: strategies to ensure an effective formulary system.
Riff L; Hutchinson R
Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
[TBL] [Abstract][Full Text] [Related]
8. Computer-based support system for formulary decisions.
Senthilkumaran K; Shatz SM; Kalies RF
Am J Hosp Pharm; 1987 Jun; 44(6):1362-6. PubMed ID: 3618613
[TBL] [Abstract][Full Text] [Related]
9. Legal issues associated with formulary product-selection when there are two or more recognized drug therapies.
Liang FZ; Greenberg RB; Hogan GF
Am J Hosp Pharm; 1988 Nov; 45(11):2372-5. PubMed ID: 3228094
[TBL] [Abstract][Full Text] [Related]
10. Achieving rational therapeutics through consensus-based protocols and follow-up.
Quintiliani R; Gousse GC; Chow MS
Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomic analysis in formulary decisions: an international perspective.
Johnson JA; Bootman JL
Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423
[TBL] [Abstract][Full Text] [Related]
12. How to develop critical paths and prepare for other formulary management changes.
McCaffrey S; Nightingale CH
Hosp Formul; 1994 Sep; 29(9):628-32, 635. PubMed ID: 10137059
[TBL] [Abstract][Full Text] [Related]
13. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
Green JA; Chawla AK; Fong PA
Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
[TBL] [Abstract][Full Text] [Related]
14. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
Segal R; Pathak DS
Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
[TBL] [Abstract][Full Text] [Related]
15. Initiation of a clinical pharmacology consult service as a formulary management tool.
Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
[TBL] [Abstract][Full Text] [Related]
16. Formulary management in an integrated health care system.
Beis SJ; Anandan JV
Pharm Pract Manag Q; 1999 Jan; 18(4):43-9. PubMed ID: 10339067
[No Abstract] [Full Text] [Related]
17. Key inventory to formulary to cut drug costs.
Schmieding JL; Sita MJ
Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
[TBL] [Abstract][Full Text] [Related]
18. The military health services system model for pharmacoeconomic decision making.
Ries AJ; Potyk RP; Brier KL; Miller MR; Tornow JJ; Weber MP; Finder SF; Reeves CS
Med Interface; 1995 May; 8(5):132-7. PubMed ID: 10142786
[TBL] [Abstract][Full Text] [Related]
19. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
Cook AA; Sanchez ML
Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
[TBL] [Abstract][Full Text] [Related]
20. Development and implementation of a comprehensive, criteria-based drug-use review program.
Todd MW; Keith TD; Foster MT
Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
